Status:
COMPLETED
A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Myopia
Eligibility:
All Genders
15-30 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the product performance of PureVision2 HD contact lenses.
Eligibility Criteria
Inclusion
- Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings
- Subjects must be myopic or hyperopic and require lens correction in each eye
- Subjects must own a pair of spectacles and the spectacle prescription must have been updated or confirmed as correct within the last 2 years.
Exclusion
- Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
- Any systemic disease affecting ocular health.
- Using any systemic or topical medications that will affect ocular physiology or lens performance.
- Allergic to any component in the Biotrue multi-purpose solution
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT01416142
Start Date
July 1 2011
End Date
September 1 2011
Last Update
December 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bausch & Lomb, Inc.
Rochester, New York, United States, 14609